Magnesium in Aneurysmal Subarachnoid Haemorrhage

Phase 3

Completed

• Conditions: Subarachnoid Haemorrhage; Blood - Other neurological disorders; Blood - Other blood disorders

• Registration Number: ACTRN12605000058673
• Lead Sponsor: Pharmalab

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-08-01
• Study Completion: 2010-04-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 162

Inclusion Criteria

<72 hours since haemorrhage

Exclusion Criteria

1/Traumatic SAH. 2/Creatinine >0.2mmol/l. 3/Myasthenia Gravis. 4/Death imminent. 5/Vasospasm present on hospital admission.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The incidence and severity of vasospasm as detected by cerebral angiography[]

Secondary Outcome Measures

Name	Time	Method
1/Mortality[];2/Glasgow Outcome Score[At 90 days.];3/ Modified Rankin [At 90 days.]